logo
NTPC completes trial operation of Unit-3 (660 MW) of the North Karanpura Super Thermal Power Project

NTPC completes trial operation of Unit-3 (660 MW) of the North Karanpura Super Thermal Power Project

NTPC Limited has announced the successful trial operation of Unit-3 (660 MW) of the North Karanpura Super Thermal Power Project (3×660 MW). With the achievement of approved norms and due approvals, the unit is now officially included in NTPC's installed capacity.
Following this addition, NTPC's total installed capacity has risen to 60,266 MW on a standalone basis and 81,368 MW on a group basis. This marks another milestone in NTPC's continued expansion of power generation capacity across India.
In the exchange filing, the company shared, 'We wish to inform that based on achievement of approved norms and due approvals, Unit-3 of 660 MW capacity of North Karanpura Super Thermal Power Project, (3 x 660 MW) has successfully completed trial operation and consequently included in the installed capacity of NTPC Limited. With this, the total installed capacity of NTPC on standalone and group basis has become 60266 MW and 81368 MW respectively.'
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lupin shares in focus after US Court rejects plea in Astellas Patent case
Lupin shares in focus after US Court rejects plea in Astellas Patent case

Business Upturn

timean hour ago

  • Business Upturn

Lupin shares in focus after US Court rejects plea in Astellas Patent case

Lupin shares were in focus after a U.S. District Court rejected the proposal filed by generic firms (Zydus & Lupin) in a legal dispute with Astellas Pharma over the interpretation of the '189 patent. The case pertains to the key urology drug G Myrbetriq (mirabegron), used to treat overactive bladder. The court's decision is seen as a setback for generic challengers seeking to enter the market with versions of the drug ahead of patent expiry. Lupin's stock opened at ₹1,998.00, touched a high of ₹2,012.90 and a low of ₹1,980.00 during the session. The stock's 52-week high stands at ₹2,402.90, while the 52-week low is ₹1,543.00. As of 9:51 AM, the shares were trading 0.59% lower at Rs 2,011.20. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

SEPC secures Rs 650 crore solar EPC contract from Parmeshi Urja
SEPC secures Rs 650 crore solar EPC contract from Parmeshi Urja

Business Upturn

time18 hours ago

  • Business Upturn

SEPC secures Rs 650 crore solar EPC contract from Parmeshi Urja

By Aman Shukla Published on June 12, 2025, 15:55 IST SEPC Limited (NSE: SEPC | BSE: 532945), a leading player in the Engineering, Procurement, and Construction (EPC) space, has been awarded a prestigious contract worth ₹650 crore by Parmeshi Urja Ltd, a Kolkata-based subsidiary of India Power Corporation Limited. The project entails the full EPC scope — including Design, Engineering, Supply, Installation, Testing, and Commissioning — of a 133 MW Solar Power Project. The solar infrastructure will be spread across four key districts in Maharashtra: Sambhaji Nagar, Dhule, Solapur, and Nanded. This green energy initiative falls under the Government of India's PM-KUSUM Yojana, which aims to boost solar adoption for agricultural and rural development. With an estimated execution timeline of 12 to 18 months, the project is a strategic leap for SEPC, marking its return to the renewable energy sector. The company, known for its past projects in Wind, Biomass, and Thermal power, is poised to deliver high-quality, large-scale infrastructure solutions. This major order almost doubles SEPC's domestic order book and strengthens its portfolio across the renewable energy domain. It also reinforces SEPC's commitment to supporting India's clean energy mission and showcases its expertise in executing technically complex infrastructure projects across multiple regions. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Nifty 50 top gainers today, June 12: Apollo Hospitals, Asian Paints, Bajaj Finserv, Dr. Reddy's and more
Nifty 50 top gainers today, June 12: Apollo Hospitals, Asian Paints, Bajaj Finserv, Dr. Reddy's and more

Business Upturn

time18 hours ago

  • Business Upturn

Nifty 50 top gainers today, June 12: Apollo Hospitals, Asian Paints, Bajaj Finserv, Dr. Reddy's and more

By Aman Shukla Published on June 12, 2025, 15:42 IST Indian equity markets closed in the red on June 12, as both benchmark indices recorded notable declines. The Sensex fell 823.16 points or 1.00% to close at 81,691.98, while the Nifty 50 dropped 253.20 points or 1.01%, ending the session at 24,888.20. Despite the broader weakness, a few Nifty 50 constituents managed to register gains. According to data from Trendlyne, here are the top gainers of the day: Nifty 50 Top Gainers on June 12 Apollo Hospitals Enterprises closed at ₹6994.00, up 1.0%. Asian Paints ended at ₹2225.00, gaining 0.7%. Bajaj Finserv closed at ₹2022.10, rising 0.5%. Dr. Reddy's Laboratories settled at ₹1356.30, up 0.4%. Tech Mahindra finished at ₹1643.60, also gaining 0.4%. Wipro ended the day at ₹259.10, with a marginal increase of 0.1%. Oil and Natural Gas Corporation closed flat at ₹247.40. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Apollo HospitalsAsian PaintsBajaj FinservDr Reddy'sNifty Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store